528201 Sigma-AldrichPNU-120596 - CAS 501925-31-1 - Calbiochem
A urea derivative that acts as a potent, selective, and reversible positive allosteric modulator for the α7 subtype of neural nicotinic acetylcholine receptors
More>> A urea derivative that acts as a potent, selective, and reversible positive allosteric modulator for the α7 subtype of neural nicotinic acetylcholine receptors Less<<同義語: α7 Neuronal Nicotinic Acetylcholine Receptor Agonist, PNU-120596, 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea, a7 nAChR agonist, PNU-120596
お勧めの製品
概要
| Replacement Information |
|---|
主要スペック表
| CAS # | Empirical Formula |
|---|---|
| 501925-31-1 | C₁₃H₁₄ClN₃O₄ |
価格&在庫状況
| カタログ番号 | 在庫状況 | 包装 | Qty/Pk | 価格 | 数量 | |
|---|---|---|---|---|---|---|
| 528201-10MGCN |
|
ガラスビン | 10 mg |
|
— |
| References | |
|---|---|
| References | Hurst, R., et al. 2005. J. Neurosci. 25, 4396. Barron, S., et al. 2009. Mol. Pharm. 76, 253. |
| Product Information | |
|---|---|
| CAS number | 501925-31-1 |
| Form | White solid |
| Hill Formula | C₁₃H₁₄ClN₃O₄ |
| Chemical formula | C₁₃H₁₄ClN₃O₄ |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥99% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| カタログ番号 | GTIN |
| 528201-10MGCN | 04055977196474 |
Documentation
PNU-120596 - CAS 501925-31-1 - Calbiochem (M)SDS
| タイトル |
|---|
PNU-120596 - CAS 501925-31-1 - Calbiochem 試験成績書(CoA)
| タイトル | ロット番号 |
|---|---|
| 528201 |
参考資料
| 参考資料の概要 |
|---|
| Hurst, R., et al. 2005. J. Neurosci. 25, 4396. Barron, S., et al. 2009. Mol. Pharm. 76, 253. |



